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ence of curdiovusculsr dysfunction on ad- 
vely studied with serial echocardiograms. 
With the increasing prcvalencc of human immunodeficicnc~ 
virus (HIV) infection, a growing number of clinical and 
pathologic studies have described cardiac involvcmont i  the 
course of the disease. Pathologic findings (1-6) include nco- 
plastic invasion from lymphoma or Kaposib ScLrcomu; valvular 
cndwarditis, either infcctivc or matantic; pcricurdial disease 
manifesting as pcricardiul effusion or fibrinous pcricarditis; 
right ventricular dilatian secondary to Pnnunocystis carinii 
pneumonia; and myocardial disease. The last has been re- 
ported in several utopsy series (S-9). Pathologic findings in 
most cases consist ofnonspecific lymphocytic myocarditis (7,8), 
but the presence of myocardial pathogens-viral, bacterial, 
protozoan and fungal- has also been reported (10-f 5). 
Since the first report by Cohen et al. (9) in 1986. an 
increasing number of cliilical and cchocardiographic studies 
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have documented dilated cardiomyopathy in HIV-positive 
(HIV ’ ) patients ( 16-19). However, there arc only few reports 
(12,18) concerning acute left ventricular dysfunction i  ac- 
quired immunodeficicncy syndrome (AIDS), with or without 
the finding of left ventricular dilation, and little is known about 
tke outcome after the acute onset. 
The aims of this study were two: 1) to determine the 
frequency with which acute left ventricular dysfunction dcvcl- 
ops in patients previously asymptomatic in the course of HIV 
infection; and 2) to correlate the presence of myocardial 
dysfunction with the pathologic findings at postmortem cxam- 
ination in the study patients. 
Patients. Between January 1988 and June 1992, lS3 HIV* 
patients were studied at .thc Institute of Infectious Diseases of 
La Sapienza University, one of the main AIDS referral centers 
in southern Italy. Only patients without cardiovascular symp- 
toms on admission were included in the follow-up study. 
Accordingly, 17 patients were not enrolled in the study proto- 
col because ofa preexisting left ventricular dysfwnctio~~ due to 
dilated cardiomyopathy (12patients) or infective cndocarditis 
(5 patients). The remaining 136 patients (104 men, 32 women; 
mean [&SD] age 33.8 + 6.5 years), either ambulatory or
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Follow-up 
Semester 
From x to 
x+l 
U-l 
I-2 
2-3 
.i-4 
d- 
~~~eli~~o~ of kute C%dxd Left Ventricuhr Dysfunction Developing in the Study Patients During the ~-O,~il{~t~-~p Period 
-.- 
Patients Still Under Patients Developing AGLVD 
Observation at 
Estinw,.,! Likelihood of 
otienls Censored Corrected Number of During Time Interval 
Beginning of Time During lntcrval Exposed Patients 
Dev~ 1, y ng AGLVD 
(no. of pathologic events) 
Interval (n,) 
During ! imc Interval 
@Q (n; = n, - $v,) (eJ (4, t!,!ll;) 
130 42 125 3 0.024 
114 28 100 2 0.020 
ES6 59 56.5 2 0.035 
27 11 21.5 0 0.0 
16 16 8 0 66.n 
AGLVD = itcutc globid Icft ventricular dysfunction. 
~~s~i~~~~z~~, were pro ectively evaluated. Eighty-two patients 
(60.2%) were i6~trave~o~s drug abusers, 30 (22.0%) were 
homosexuals, a66d 24 (17.8%) 
were classified as follows: ant 
S%); A~~S-~e~ate(~ 
(93 patients, o&4% 
or each pirtient, with attentio66 to cardiovascular risk 
factors, such as family history of corona6y artc6y disease, 
hypertension, diabetes rne~lil~s and alcohol abuse (>(,(I g/day). 
Recent admi66istration of cardiotoxic drtrgs was also evaluated. 
At the time of referral, all patients underwent electrocardio- 
assessment and chest radiography. All 
ounts. Zidovudi66e (AZT) was being admin- 
s (69.1%). 
y. Each patient with AI 
plex and AIDS u66denve66t 6nedical examination on a mo66tbly 
basis. Echocardiography was performed every 4 mo66ths unless 
an earlier control echocardiogram was required (two to five 
echocardiograms per patient, at a mean interval of 93 days). 
Quantitative M-mode, two-dimensional and Doppler echo- 
cardiography were performed according to the criteria of the 
American Society of Echocardiography (20) using a L-lewlett- 
Packard ultrasound machine. The following variables were 
analyzed: left and right ventricular end-diastolic and end- 
systolic diameters corrected for body surface area, left ventric- 
ular fractional shortening on M-mode echocardiography and 
left ventricular end-diastolic and end-systolic areas on two- 
dimensional echocardiography. Left ventricular volumes and 
ejection fraction were measured using a modification of Simp 
son’s rule (21-23). Left ventricular diastolic diameter was 
considered abnormal if it was >3.2 cm/m’ (16). The upper 
limit of 66ormal value for right ventricular diastolic diameter 
was considered to be I .4 cm/m’ (24). The lower limit of normal 
value was assumed to be 45% for ejection fraction and 28% for 
fractional shortening (19). Valvular regurgitation was analyzed 
semiquantitatively utilizing Doppler waves, as previously re- 
ported (25). All measurements were made by two investigators 
(S.D.C., DC.). Informed consent was obtained from each 
patient before echocardiographic examination. The mean in- 
traobserver and interobserver differences between M-mode 
and two-dimensional echocardiographic variables (1.5% and 
3.9%, respectively) and between pulsed and continuous wave 
Doppler measurements (1.4% and 2.9%, respectively) were 
not significantly different from zero. 
rmsis. Clinical diagnosis of acute global left 
66ction was based on the following criteria: 
) symptoms of acute heart failure; 2) ccl~oca~~i~~~~p~~ic 
ndings of diffuse ventricular hypokinesia, as shown by de. 
creased left ve66tricular ejection fraction (~45%) and frac- 
tional shortening (<28%); 3) chest X-ray film with bilateral 
and diffuse signs of interstitial pulmonary edema and pulmo- 
ni66-y venows hypertension. The presence of left vcntricula6 
dilation (>3.2 cmhnz) was not required as a necessary diag- 
nostic criterio66 for acute global left ventricular dysfunction. 
Indeed, in most patiei:ts the left ventricular dimension was 
logic exa~~~at~on. Whenever co66sent was obtained, 
ng the follow-up period underwent a 
rts were carefully examined to assess 
presence and extent of coro66ary artery 
atherosclerosis and occurrence of myocardial or valvular ab- 
normalities. 
In each case, multiple myocardial samples were taken, fixed 
in IO% butfered formalin and routinely processed for histo- 
logic examination. Sectio66s 5 pm thick were stai66ed with 
hcmatoxylin-eosin and special stains for organisms, including 
fungi, protozoa and acid-fast bacilli. Immunohistochemistry 
was performed to detect cytomegalovirus. 
§tat~st~cal evaluation. Data are expressed as mean value ?Z 
SD. The Fisher exact test was used to compare mean values, 
and p < 0.05 was considered significant. The estimated likeli- 
hood of developing acute global left ventricular dysfunction in 
the follow-up period was calculated by a modified Berkson and 
Gage (26) survival table. 
During a mean follow-up time of 415 2 220 days, seven 
patients (five men, t?vo women; mean age 33 + 9 years) 
complained of severe dyspnea of sudden onset (Table 1). 
Clinical diagnosis of acute global left ventricular dysfunction 
was made according to the aforementioned criteria. The Onset 
of left ventricular hypokinesia could be timed accurately in 
these patients because they were repeatedly evaluated by 
echocardiography. Echocardiographic findings at the last 
baseline study and at the time of diagnosis are described in 
Table 2. 
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Table 2, Clinical Features of the Seven Patients With Acut b .Sidbal Left Ventricular Dysfunction a d Their Echocardiographic Findings at 
Last Bast$ne Study and at Echocardiographic Diagnosis 
Pt No./ Age Risk Infections/ TI LVEDD LVFS LVEF RVEDD 
Cardiac Doppler Findings 
Gender (yr) Factors Disease Stage Neoplasms (days) Study (cm/ma) (%) (%) (cm/m’) PE PR TR MR AoR 
1iM 31 IVDA AIDS (IV Cl) SC Baseline: 2.9 36 62 1.2 - f + - - 
86 Diagnosis: 3.2 16 24 1.3 + t t tt+ - 
?/M 51 HS AfDS(IVC1) CT Baseline: 2.9 34 62 0.9 - - - + 
105 Diagnosis 3.2 19 35 0.9 - - - t - 
3/M 31 IVDA AfDS(WC1) CT Baseline: 2.7 36 60 1.1 - - - - - 
120 Diagnosis: 2.7 21 3tl 1.1 t + t + 
4/M 25 HS AIDS (W D) KS Baseline: 3.0 33 60 1.2 - - + + 
- 
92 Diagnosis: 3.7 17 25 1.6 + + t tt/ttt - 
S/F 28 PAR AlDS(IVCI) PCP Baseline: 2.8 34 65 1.0 i- t t - - 
5x Diagnosis: 3.5 17 30 1.0 c + t tt/ttt - 
6/M 31 IVDA AfDS(1VCl) PCP Lkeline: 2.6 35 65 1.0 - + t t 
74 Diagnosis: 3.2 18 28 I.1 + t t t 
7/F 26 IVDA AIDS (IV Cl) PCP Baseline: 2.7 34 60 I.1 + - $ - - 
65 Diagnosis: 3.0 19 22 1.2 t t t ttittt - 
AIDS = acquired immunodekienq syndrome; AoR = aortic regurgitation; CT = cerebral toxoplasmosis; F - female; HS = homosexual; KS = Kaposi’s sarcoma: 
IVDA = intravenous druy addict; LVEDD = left ventricular end.diastolic diameter; LVEF = left ventricular ejection fraction: LVFS = left ventricular fractional 
shortening: M = male; MR = mitral regurgitation: PAR = partner at risk; PCP = hcrtmoc~rris carhi pneumonia; PE = pericardial effusion; PR = pulmommy 
rqqitation; Pt = patient; RVEDD = right vcntriiular end-diastolic diameter: SC = systemic cryptococcosis; TI = time interval between last baseline study and 
echocardiographic diagnosis; TR = tricuspid regurgitation; - = absent; + = trivial: + t = mild; t t t = moderate. 
In five patients, left ventricular volume was within normal 
limits. One patient (Patient 4) had biventricular dilation, and 
another (Patient 5) had left ventricular dilation only. One of 
the patients without left ventricular dilation (Patient 1) had 
mild right ventricular enlargement. A slightly increased left 
ventricular wall thickness was observed in only one patient 
(Patient 7). In all patients the left ventricle was severely 
hypokinetic, as shown by a decrease in both left ventricular 
fractional shortening (mean 18.9 C 1.6) and ejection fraction 
(mean 27.7 c 4.4). Doppler studies demonstrated a mild 
pulmonic and tricuspid insufficiency in six of seven patients, 
and mild or moderate mitral regurgitation was present in all 
patients. None had aortic regurgitation. Six patients had mild 
ricardial effusion that was not hemodynamically significant. 
Electrocardiographic abnormalities, such as tachycardia, 
supraventricular and ventricular ectopic beats and ventricular 
apolarization abnormalities, were observed in all seven pa- 
tients. 
The mean CD4 count in these seven patients was 56/mm3, 
as opposed to 107/m& in patients without acute global left 
ventricular dysfunction (p = NS). This lower count is probably 
related to their being in the AIDS stage. In fact, the mean CD4 
count for the overall subset of patients with AIDS was 5g/mm3. 
Six (R%) of the seven patients with acute global left 
ventricular dysfunction died of irreversible left ventricular 
failure (Table 3), with clinical signs of tachycardia, dyspnea 
with pulmonary rales and third heart sound (S, gallop). The 
mean time elapsed between the onset of those signs and death 
was 41 ? 13 days. 
Five patients underwent autopsy; consent was denied for 
one patient. On gross examination, mean cardiac weight was 
280 g (range 235 to 410). Hearts showed no evidence of 
valvular disease, significant (>70%) coronary artcry stenosis or 
myocardial necrosis or scarring. Mild left ventricular dilation 
had been observed in vivo in Patients 4 and 5 and was 
reversible in the latter. Autopsy confirmed the clinical finding 
of left ventricular dilation in Patient 4; in addition, a slightly 
enlarged left ventricle was observed in Patient 7. 
In four of five patients (Table 3) a histologic diagnosis of 
acute myocarditis was feasible according to the Dallas criteria 
(27). 
One patient (Patient 1) had systemic cryptococcosis with 
myocardial involvement. Three (Patients 2 to 4) had acute 
lymphocytic myocarditis with a variable extent of inflammatory 
infiltrate and myocyte damage (Fig. 1 and 2, Table 3). Special 
stains did not disclose fungi, mycobacteria or protozoa, such as 
Table 3. Clinical Outcome and Autopsy Findings for the Seven 
Patients With Acute Global Left Ventricular Dysfunction 
Pt 
No. Evolution 
Survival 
Time 
(days) Autopsy Findings 
I Death 33 Cryprococcus myocarditis, scarce 
infiltrate 
2 Death 52 Lymphocytic myocarditis, moderate focal 
infiltrate 
3 Death 41 Lymphocytic myocarditis, mild focal 
infiltrate 
4 Death 54 Lymphocytic myocarditis, severe diffuse 
infiltrate 
5 Reversible LVD 
6 Death 47 Autopsy not performed 
7 Death 20 Interstitial edema and fibrosis 
LVD = left ventricular dysfunction; Pt = patient. 
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igure 1. Lymphocytic myocarditis with exten- 
slve inflnmmatory infiltrates and myocyte dam- 
ematoxylin-eosia, X35. 
T~x~)~~~(lsv~tu g0&. Immldnoslistochemical analysis for cyto- 
megalovirus gave negative results. n the only patient without 
myocarditis (Patient 7) histology revealed mild interstitial 
edema and fibrosis (Fig. 3), with focal vacuolar changes in 
myocytes in the absence of inflammation. Special stains, in- 
cluding immunohistochemistry fo  cytomegalovirus, were all 
negative. 
The only patient with reversible acute global left ventricular 
dysfunction (Patient 5) was taking lithium salts at the time of 
symptom onset. Echocardiography demonstrated a severe de- 
crease in contractility, with significant left ventricular dilation. 
There were mild pericardial effusion and moderate mitral 
regurgitation. Although renal function was within normal 
limits, toxic myocarditis was suspected because of the known 
myocardial effects of this drug (28), and lithium was discontin- 
ued. Within 1 month after lithium withdrawal, there was an 
improvement in left ventricular function, and serial echocar- 
iograms howed an increased lcfi ventricular contractility and 
regression of mitral regurgitation, 
Other cardiac a~no~~~~iEies. During the follow-up period, 
chronic dilated cardiomyopathy developed in 5 (5.4%) of the 
93 patients within the AIDS subgroup (Table 4). They all had 
mild dyspnea nd echocardiographic evidence of progressive 
biventricular dilation (Table 5) with decreased global contrac- 
tility. Only one patient died during the follow-up interval. 
Autopsy disclosed Pmwmystis carinii pneumonia nd con- 
firmed the diagnosis of dilated cardiomyopathy. 
Wall motion and wall-thickening abnormalities were ob- 
served in 10 of 136 patients (7 with AIDS, 2 with AIDS-related 
complex, and 1 HIV+). The abnormalities were confined to the 
intcrvcntricular septum and were associated with normal mea- 
suremeots of global left ventricular function. Three patients 
died of noncardiac auses. Autopsy did not disclose any 
myocardial damage. 
Figure 2. Lymphocytic myocarditis 
inflammation and myocyte damage. 
Hematoxylin-eosin, X35. 
with mild 
Patient 3. 
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Figure 3. Interstitial fibrosis and edema, with 
focal vacuolar changes of myOCyteS, in absence of 
inflammatory infiltrates. Patient 7. Hematoxylin- 
cosin, X35. 
p During the follow-up period, a total of 47 
of ients died of noncardiac causes. Autopsy was 
performed in 20 patients. In two patients, histologic examina- 
tion of the heart revealed mild lymphocytic infiltration in the 
absence of myocyte damage, which did not fulfill the Dallas 
criteria for a diagnosis of myocarditis. 
iscussion 
Cad&c rrbaomalities :n HIV+ patients. The natural his- 
tory of HIV infection can be complicated by myocardial 
dysfunction, the prevalence of which ranges from 10% to 42% 
(3). In our series, a considcrahle number of patients (39 
(25.5%] of 153) showed some form of cardiac abnormality 
either at the referral or during the follow-up period. However, 
the tertiary nature of our ,series dots not allow us to infer the 
prevalence of cardiac involvement in AIDS in the general 
population. 
In our series the following cardiac diseases were obsetvcd: 
infective endocarditis (5 patients at referral), dilated cardio- 
myopathy (12 patients at referral, 5 during follow-up) and 
acute global left ventricular dysfunction (7 patients during 
follow-up). In addition, IO patients developed segmental wall 
motion and thickening abnormalities during follow-up. 
The cardiac abnormalities described in HIV’ patients often 
Tabk b Clinical Features of the Five Patients With Chronic 
Dilated Cardiomyopathy 
PtN0.I A& Disease 
Gender Or) Risk Factor StQ!e Infcction/Nwplasm 
IIM 39 IVDA AIDS HL 
mi 30 IVDA AIDS hfjcolmctehun 
3m 33 HS AIDS KS 
w 53 PAR AIDS PCP 
s/F 31 PAR AIDS PCP 
HL = Hodgkin’s hlmphoma; other abbreviations as in Table 2. 
consist of dilated cardiomyopathy (3,6,9,16,19). Altllo~gh the 
occurrence of left ventricular dysfunction in HIV’. patients has 
been described by several investigators (O-16,;3), there is little 
information on the evolution of the disease, especially in cases 
of acute left ventricular dysfunction. 
Our prospective study was designed to address this issue 
and to investigate the possible causes of acute global left 
ventricular dysfunction. Accordingly, HIV’ patients with clin- 
ical features of dilated cardiomyopathy already evident at the 
time of referral were not included in the study. 
Acute global eft ventricular dysfunction. According to our 
results, the frequency of the disease wihin the entire study 
group was 5.1% (7 of 136). However, all arfected patients were 
in the AIDS subgroup, which made the relative frequency of 
acute global left ventricular dysfunction 7.5% (7 of 93) in the 
AIDS stage of the disease. The estimated likelihood of devel- 
oping acute global left ventricular dysfunction was at least 
2.0% per serrestcr in the 1st I8 months of follow-up (Table 1). 
In the subsequent periods, acute global left ventricular dys- 
function was no longer observed: this probably reflected the 
small number of patients still under ohservation af!cr the 1st I8 
months of follow-up and their being in the HIV’ subgroup. 
Echocardiography was the metho.l of choice to highlight 
poor left ventricular contractile function and the possibility of 
left ventricular dilation in this selected group of patients. 
Patients with AIDS frequently develop opportunistic pulmo- 
nary infections with dyspnea, and problems in differential 
clinical diagnosis with cardiovascular diseases may arise (3). 
Accordingly, echocardiographic evaluation should routinely be 
performed in patients with AIDS with dyspnea. Although in 
our series the occurrence of acute global left ventricular 
dysfunction was relatively low (7.5%), there was a high mor- 
tality rate from the disease (85%), thus making echocardiog 
raphy quite helpful in the clinical diagnosis and management 
of acute myocardial dysfunction in AIDS. 
In our study, a clinical diagnosis of acute myoizarditis was 
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Pt 
No. 
1 
2 
3 
1 
5 
Baseline 
LVEVV LVEF 
(cmim’) (?) 
2.7 61 
2.6 63 
2.8 63 
2.7 65 
2.7 62 
Time 
to 2nd 
Study 
(days) 
120 
120 
100 
120 
110 
2nd Study 
LVEVV LVEF 
(cm/m’) (‘i ) 
3.0 SO 
2.1 60 
2.‘) j0 
3.1 5; 
3.0 50 
Time 
to 3rd 
Smdy 
(days) 
120 
I20 
131 
64 
120 
3rd Study 
LVEVV LVEF 
(cm/m’) (‘i) 
3.1 48 
3.0 55 
3.0 52 
3.2 53 
3.3 30 
Time 
to 4ti1 
Study 
(days) 
100 
95 
83 
120 
I20 
4th Study Time 
to Sth 
5th Study 
LVEVD LVEF Study LVEVV LVEF 
(cm/m’) (“i,) (days) (cm/m’) (%) 
3.1 46 120 3.3 40 
3.2 40 110 3.4 35 
3.3 45 120 3.5 40 
3.3 42 72 Exitus 
3.3 40 90 3.4 35 
Ahhrcviations as in Table 1. 
suspoeted on the basis of symptoms, rapid evolution and 
echocardiograpbic findings of S~WK Ml veutkdilr hypokiw 
si;i with or without Idt vcW%Xh dilation. As previously 
reported (3(l), the finding of increased left ventricular wall 
thickness was infrequent in our patient group, aud it was of no 
aid in the diagnosis of myociuditis. 
ologic S. At autopsy, the clinical suspicion of 
myocarditis was confirmed in four (80%) of five patients. Our 
results show that there is a correlation between clinical signs of 
acute left ventricular dysfunction and pathologic findings of 
acute myocarditis. This observation is also supported by the 
absence of histologic features of myocarditis in the hearts of all 
patients who died of noncardiac causes. In one patient only was 
an offending pathogen (C~~~~fococcus) identified. 
In our series the extent of myocardial inflammation and 
damage (Table 3) did not correlate with the severity of global 
left ventricular dysfunction and clinical outcome. This is in 
agreement with a previous report (8). This phenomenon might 
be explained by the presence of concomitant damaging factors 
at the myocardial level, independent of the extent of the 
inflammatory infiltrate. The HIV has recently been identified 
in cardiac myocytes by in situ hybridization techniques (31,32); 
myocyte damage could be a result of the release of viral 
proteases (33,34). However, one cannot exclude the possibility 
that the presence of disease elsewhere, besides the heart, may 
influence the clinical outcome of myocarditis in this subset of 
patients. 
Only one patient (Patient 7) manifested acute global left 
ventricular dysfunction in the absence of myocarditis. At 
autopsy, there were histologic findings of myocyte vacuolar 
degeneration, mild interstitial fibrosis and edema. These find- 
ings, although nonspecific, are suggestive of myocardial dam- 
age and could be consistent with an acute onset of cardiomy- 
opathy. 
Dilated cardiomyopathy versus acute left ventricular dys- 
function. At variance with myocardial dysfunction of acute 
onset, chronic dilated cardiomyopathy developed in tive other 
patients with AIDS of our series during the follow-up period 
(Table 4). The gradual course of the disease is shown by the 
progressive change in echocardiographic findings (Table 5). 
Only one patient died of noncardiac causes during the follow-up 
period. The different course and mortality rate suggest that acute 
global left ventricular dysfunction is a dilferent clinical entity from 
chronic dilated cardiomyopathy. 
hSSibk causes of secondary dilated cardiomyopathy iu 
patients with AIDS include nutritional deficiencies (3), pri- 
IV-induced myocardial damage (30,35,36) or antiret- 
roviral drug toxicity. The last has recently been described 
(4,37,38) in patients taking zidovudine or other dideoxynucleo- 
sidcz in high doses. In our series a large number of patients 
(69.1%) were taking zidovudine; however, the doses 
(500 mglday) were always below those reported to be cardio- 
toxic. 
Conclusions. Acute global left ventricular dysfunction can 
occur in HIV+ patients. Although infrequent, this entity is not 
rare in the AIDS population and seems to occur exclusi-Jely in 
this subgroup. Acute global left ventricular dysfunction can be 
associated with myocarditis, acute onset of cardiomyopathy or 
toxic myocardial damage. According to our results, the first 
two conditions are always fatal, but the third can be reversed. 
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